Basic Info

Common NameAurovertin D(F04996)
2D Structure
Description

Aurovertin B is a mycotoxin and antibiotic produced by the fungus Calcarisporium arbuscula. It is known for its ability to inhibit oxidative phosphorylation. (A3002, A3032)

FRCD IDF04996
CAS Number65256-31-7
PubChem CID6438901
FormulaC25H32O9
IUPAC Name

[2-hydroxy-6-(1-hydroxyethyl)-3-[(1E,3E,5E)-6-(4-methoxy-3-methyl-6-oxopyran-2-yl)hexa-1,3,5-trienyl]-1,5-dimethyl-4,7-dioxabicyclo[3.2.1]octan-8-yl] acetate

InChI Key

UKPVUEBWITXZRF-BGSVYHRFSA-N

InChI

InChI=1S/C25H32O9/c1-14-17(32-20(28)13-19(14)30-6)11-9-7-8-10-12-18-21(29)24(4)23(31-16(3)27)25(5,33-18)22(34-24)15(2)26/h7-13,15,18,21-23,26,29H,1-6H3/b8-7+,11-9+,12-10+

Canonical SMILES

CC1=C(OC(=O)C=C1OC)C=CC=CC=CC2C(C3(C(C(O2)(C(O3)C(C)O)C)OC(=O)C)C)O

Isomeric SMILES

CC1=C(OC(=O)C=C1OC)/C=C/C=C/C=C/C2C(C3(C(C(O2)(C(O3)C(C)O)C)OC(=O)C)C)O

Synonyms
        
            Aurovertin D
        
            65256-31-7
        
            AC1O5QL4
        
            [2-hydroxy-6-(1-hydroxyethyl)-3-[(1E,3E,5E)-6-(4-methoxy-3-methyl-6-oxopyran-2-yl)hexa-1,3,5-trienyl]-1,5-dimethyl-4,7-dioxabicyclo[3.2.1]octan-8-yl] acetate
        
            2H-Pyran-2-one, 6-(6-(8-(acetyloxy)-4-hydroxy-7-(1-hydroxyethyl)-1,5-dimethyl-2,6-dioxabicyclo(3.2.1)oct-3-yl)-1,3,5-hexatrienyl)-4-methoxy-5-methyl-
        
Classifies
                

                  
                    Fungal Toxin
                  

                
        
Update DateNov 13, 2018 17:07

Chemical Taxonomy

KingdomOrganic compounds
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds
SubclassCarbohydrates and carbohydrate conjugates
Intermediate Tree NodesGlycosyl compounds
Direct ParentC-glycosyl compounds
Alternative Parents
Molecular FrameworkAromatic heteropolycyclic compounds
SubstituentsC-glycosyl compound - 1,4-dioxepane - Alkyl aryl ether - Pyranone - Dioxepane - Pyran - Oxane - Heteroaromatic compound - Vinylogous ester - Tetrahydrofuran - Carboxylic acid ester - Secondary alcohol - Lactone - Oxacycle - Carboxylic acid derivative - Organoheterocyclic compound - Dialkyl ether - Monocarboxylic acid or derivatives - Ether - Alcohol - Hydrocarbon derivative - Organic oxide - Carbonyl group - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as c-glycosyl compounds. These are glycoside in which a sugar group is bonded through one carbon to another group via a C-glycosidic bond.

Properties

Property NameProperty Value
Molecular Weight476.522
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count8
Complexity975
Monoisotopic Mass476.205
Exact Mass476.205
XLogP1.1
Formal Charge0
Heavy Atom Count34
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count7
Defined Bond Stereocenter Count3
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

ADMET

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.5325
Human Intestinal AbsorptionHIA+0.7077
Caco-2 PermeabilityCaco2+0.5204
P-glycoprotein SubstrateSubstrate0.6576
P-glycoprotein InhibitorInhibitor0.5737
Non-inhibitor0.5591
Renal Organic Cation TransporterNon-inhibitor0.8834
Distribution
Subcellular localizationMitochondria0.7058
Metabolism
CYP450 2C9 SubstrateNon-substrate0.7545
CYP450 2D6 SubstrateNon-substrate0.8849
CYP450 3A4 SubstrateSubstrate0.5254
CYP450 1A2 InhibitorNon-inhibitor0.9177
CYP450 2C9 InhibitorNon-inhibitor0.8623
CYP450 2D6 InhibitorNon-inhibitor0.8830
CYP450 2C19 InhibitorNon-inhibitor0.6766
CYP450 3A4 InhibitorNon-inhibitor0.5618
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.6816
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.9906
Non-inhibitor0.9351
AMES ToxicityAMES toxic0.5799
CarcinogensNon-carcinogens0.9247
Fish ToxicityHigh FHMT0.9667
Tetrahymena Pyriformis ToxicityHigh TPT0.9871
Honey Bee ToxicityHigh HBT0.7547
BiodegradationNot ready biodegradable0.9810
Acute Oral ToxicityII0.4053
Carcinogenicity (Three-class)Danger0.6478

Model Value Unit
Absorption
Aqueous solubility-3.3779LogS
Caco-2 Permeability0.7705LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity3.2930LD50, mol/kg
Fish Toxicity-0.1257pLC50, mg/L
Tetrahymena Pyriformis Toxicity1.5801pIGC50, ug/L

Targets

General Function:
Transporter activity
Specific Function:
Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Subunits alpha and beta form the catalytic core in F(1). Rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of ATP in three separate catalytic sites on the beta subunits.
Gene Name:
ATP5B
Uniprot ID:
P06576
Molecular Weight:
56559.42 Da
Mechanism of Action:
Aurovertins are a mixed, noncompetitive inhibitors of both ATP hydrolysis and synthesis. They do this by inhibiting the proton-pumping F1F0-ATP synthase by binding to beta-subunits in its F1 catalytic sector. F1F0-ATP synthase is responsible for the terminal step of oxidative phosphorylation. Each ATP synthase complex has three beta subunits, and aurovertins are believed to bind with varying affinity to two subunits on sites in a cleft between the nucleotide-binding and C-terminal domains, thus preventing closure of the catalytic interfaces necessary for the cyclic interconversion of catalytic sites.
References
  1. Johnson KM, Swenson L, Opipari AW Jr, Reuter R, Zarrabi N, Fierke CA, Borsch M, Glick GD: Mechanistic basis for differential inhibition of the F1Fo-ATPase by aurovertin. Biopolymers. 2009 Oct;91(10):830-40. doi: 10.1002/bip.21262. [19462418 ]